Jushi (OTCMKTS:JUSHF – Get Free Report) is one of 54 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its peers? We will compare Jushi to similar companies based on the strength of its profitability, earnings, dividends, institutional ownership, analyst recommendations, risk and valuation.
Institutional & Insider Ownership
21.7% of Jushi shares are owned by institutional investors. Comparatively, 15.3% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 21.0% of Jushi shares are owned by insiders. Comparatively, 20.9% of shares of all “Medicinals & botanicals” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Jushi and its peers revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Jushi | $269.45 million | -$65.10 million | -2.18 |
Jushi Competitors | $304.70 million | -$158.43 million | -10.47 |
Analyst Ratings
This is a summary of recent recommendations and price targets for Jushi and its peers, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Jushi | 0 | 2 | 0 | 0 | 2.00 |
Jushi Competitors | 244 | 545 | 913 | 66 | 2.45 |
As a group, “Medicinals & botanicals” companies have a potential upside of 56.52%. Given Jushi’s peers stronger consensus rating and higher possible upside, analysts clearly believe Jushi has less favorable growth aspects than its peers.
Volatility & Risk
Jushi has a beta of -0.16, meaning that its stock price is 116% less volatile than the S&P 500. Comparatively, Jushi’s peers have a beta of 1.39, meaning that their average stock price is 39% more volatile than the S&P 500.
Profitability
This table compares Jushi and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Jushi | -24.16% | -214.72% | -10.10% |
Jushi Competitors | -52.00% | -55.96% | -9.06% |
Summary
Jushi peers beat Jushi on 8 of the 12 factors compared.
Jushi Company Profile
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.
Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.